中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2014年
9期
652-657
,共6页
常鹏宇%崔爽%姜新%曲超%蒋鑫萍%罗景华%曲雅勤%董丽华
常鵬宇%崔爽%薑新%麯超%蔣鑫萍%囉景華%麯雅勤%董麗華
상붕우%최상%강신%곡초%장흠평%라경화%곡아근%동려화
脂肪干细胞%放射性肠损伤%血管%修复
脂肪榦細胞%放射性腸損傷%血管%脩複
지방간세포%방사성장손상%혈관%수복
Adipose-derived mesenchymal stem cells%Radiation-induced intestinal injury%Blood vessel%Repairation
目的:评价人源脂肪干细胞对辐射诱导的肠血管损伤的修复作用。方法选用成年雄性SD大鼠,共34只,给予全腹部15 Gy X射线照射。造模后,取其中17只给予P6代人源脂肪干细胞腹腔注射治疗( Ad-MSC治疗组);另17只大鼠给予双磷酸盐缓冲液( PBS)腹腔注射治疗( PBS溶剂对照组)。照射后第10天,流式细胞分析绒毛内CD31阳性内皮细胞的数量,免疫荧光染色分析新生的血管内皮细胞,免疫组织化学染色分析血管结构的连续性;并提取受照小肠组织总RNA,实时荧光定量PCR检测受照组织内基质细胞起源因子-1(SDF-1)、血管内皮细胞生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)以及血管内皮细胞生长因子受体(Flk-1)的表达量。检测Ad-MSC治疗组的受损小肠内新生的内皮细胞来源。结果与PBS溶剂对照组相比,Ad-MSC能够显著增加受损组织内CD31阳性内皮细胞数量(t=12?15,P<0?05),提高受损组织内的血管密度(20 d:t=10?33,P<0.05;30 d:t=32?85,P<0?05),上调血管生成基因VEGF、bFGF、Flk-1以及SDF-1的表达量(t=10?34、11?25、6?73、6?73,P<0?05)。维持受损部位小肠绒毛内的血管完整,并促进CD31阳性造血干/祖细胞向血管内皮细胞的分化,加速受损部位血管的新生。结论人源脂肪干细胞通过发挥促血管新生的作用来修复辐射诱导的肠血管损伤。
目的:評價人源脂肪榦細胞對輻射誘導的腸血管損傷的脩複作用。方法選用成年雄性SD大鼠,共34隻,給予全腹部15 Gy X射線照射。造模後,取其中17隻給予P6代人源脂肪榦細胞腹腔註射治療( Ad-MSC治療組);另17隻大鼠給予雙燐痠鹽緩遲液( PBS)腹腔註射治療( PBS溶劑對照組)。照射後第10天,流式細胞分析絨毛內CD31暘性內皮細胞的數量,免疫熒光染色分析新生的血管內皮細胞,免疫組織化學染色分析血管結構的連續性;併提取受照小腸組織總RNA,實時熒光定量PCR檢測受照組織內基質細胞起源因子-1(SDF-1)、血管內皮細胞生長因子(VEGF)、堿性成纖維細胞生長因子(bFGF)以及血管內皮細胞生長因子受體(Flk-1)的錶達量。檢測Ad-MSC治療組的受損小腸內新生的內皮細胞來源。結果與PBS溶劑對照組相比,Ad-MSC能夠顯著增加受損組織內CD31暘性內皮細胞數量(t=12?15,P<0?05),提高受損組織內的血管密度(20 d:t=10?33,P<0.05;30 d:t=32?85,P<0?05),上調血管生成基因VEGF、bFGF、Flk-1以及SDF-1的錶達量(t=10?34、11?25、6?73、6?73,P<0?05)。維持受損部位小腸絨毛內的血管完整,併促進CD31暘性造血榦/祖細胞嚮血管內皮細胞的分化,加速受損部位血管的新生。結論人源脂肪榦細胞通過髮揮促血管新生的作用來脩複輻射誘導的腸血管損傷。
목적:평개인원지방간세포대복사유도적장혈관손상적수복작용。방법선용성년웅성SD대서,공34지,급여전복부15 Gy X사선조사。조모후,취기중17지급여P6대인원지방간세포복강주사치료( Ad-MSC치료조);령17지대서급여쌍린산염완충액( PBS)복강주사치료( PBS용제대조조)。조사후제10천,류식세포분석융모내CD31양성내피세포적수량,면역형광염색분석신생적혈관내피세포,면역조직화학염색분석혈관결구적련속성;병제취수조소장조직총RNA,실시형광정량PCR검측수조조직내기질세포기원인자-1(SDF-1)、혈관내피세포생장인자(VEGF)、감성성섬유세포생장인자(bFGF)이급혈관내피세포생장인자수체(Flk-1)적표체량。검측Ad-MSC치료조적수손소장내신생적내피세포래원。결과여PBS용제대조조상비,Ad-MSC능구현저증가수손조직내CD31양성내피세포수량(t=12?15,P<0?05),제고수손조직내적혈관밀도(20 d:t=10?33,P<0.05;30 d:t=32?85,P<0?05),상조혈관생성기인VEGF、bFGF、Flk-1이급SDF-1적표체량(t=10?34、11?25、6?73、6?73,P<0?05)。유지수손부위소장융모내적혈관완정,병촉진CD31양성조혈간/조세포향혈관내피세포적분화,가속수손부위혈관적신생。결론인원지방간세포통과발휘촉혈관신생적작용래수복복사유도적장혈관손상。
Objective To assess the therapeutic effect of human adipose-derived mesenchymal stem cells on radiation-induced vascular injury in the small intestine of rat. Methods A total of 34 male Sprague-Dawley rats were enrolled in this study. To establish a model of radiation-induced intestinal injury, each rat was irradiated with 15 Gy in whole abdomen. 17 rats were randomly selected and infused intraperitoneally with passage 6 ( P6 ) Ad-MSCs, and the other 17 rats that received PBS were set as control. 10 days post-irradiation, the number of CD31+ endothelial cells in the small intestine villus was measured by flow-cytometry, the expressions of CD31, CD105 and isolectin-B4 in the na?ve endothelial cells with detected by IHC-staining, and the vascular integrity was evaluated by measuring VE-Cadherin. The origination of na?ve endothelial cells within injured intestine was also analyzed. In addition, total mRNA were extracted from irradiated small intestine to assay the expressions of VEGF, bFGF, Flk-1 and SDF-1 using quantitative Real-time PCR. Results Compared to the control, the amount of CD31-postive endothelial cells within irradiated intestine was significantly increased after Ad-MSCs infusion ( t=12?15, P<0?05). The microvascular density in the injured sites was also significantly increased by the infusion of Ad-MSCs (20 d:t=10?33, P<0. 05;30 d:t=32?85, P<0?05). Moreover, the expressions of VEGF, bFGF, Flk-1 and SDF-1 were significantly up-regulated after delivery of Ad-MSCs ( VEGF:t =10?34, bFGF:t=11?25,Flk-1:t=6?73, SDF-1:t=6?73, all P<0?05), which was beneficial in maintaining the integrity of intra-villus blood-vessels as well as promoting neovascularization in the injured sites. Conclusion Ad-MSCs had potentials in healing radiation-induced vascular injury in rat small intestine.